Production (Stage)
Johnson & Johnson
JNJ
$152.94
$0.330.22%
NYSE
| 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.39% | 5.26% | 5.25% | 4.31% | 2.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.39% | 5.26% | 5.25% | 4.31% | 2.34% |
| Cost of Revenue | 11.45% | 6.03% | 5.91% | 6.27% | 0.26% |
| Gross Profit | -1.58% | 4.92% | 4.96% | 3.47% | 3.28% |
| SG&A Expenses | -0.92% | 11.90% | 2.14% | 8.14% | 10.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.53% | 11.31% | 13.31% | 3.63% | 3.99% |
| Operating Income | 2.03% | -15.47% | -13.67% | 5.95% | -1.39% |
| Income Before Tax | 267.02% | -19.46% | -36.02% | -8.85% | 388.58% |
| Income Tax Expenses | 473.42% | -34.29% | -29.07% | 14.19% | 157.66% |
| Earnings from Continuing Operations | 237.91% | -16.97% | -37.48% | -12.83% | 762.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 237.91% | -15.26% | -89.65% | -8.90% | 4,886.76% |
| EBIT | 2.03% | -15.47% | -13.67% | 5.95% | -1.39% |
| EBITDA | 1.05% | -4.96% | -10.41% | 2.71% | -1.86% |
| EPS Basic | 238.06% | -3.41% | -89.15% | -1.65% | 5,278.54% |
| Normalized Basic EPS | 3.99% | -13.89% | -4.91% | 15.87% | 8.59% |
| EPS Diluted | 238.81% | -3.38% | -89.13% | -1.61% | 4,937.55% |
| Normalized Diluted EPS | 4.22% | -13.89% | -4.73% | 16.36% | 7.60% |
| Average Basic Shares Outstanding | -0.04% | -12.27% | -4.59% | -7.37% | -7.57% |
| Average Diluted Shares Outstanding | -0.26% | -12.27% | -4.78% | -7.76% | -6.73% |
| Dividend Per Share | 4.20% | 4.20% | 4.20% | 4.20% | 5.31% |
| Payout Ratio | -0.69% | 0.23% | -- | 0.06% | 1.02% |